<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-3-4.anc" start="12213" end="12218" sStart="12166" offset="47" sid="r7.1.use.v.0981" wn="1" wnkey="use%2:34:01::" text="Thus, if the infectivity is compared using the actual number of viral particles present in each well, Ad5.CMV-LacZ, immobilized on streptavidin-coated wells, may possess an infectivity equivalent to that of free adenoviral vectors." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-3-4.anc" start="23758" end="23762" sStart="null" offset="281" sid="r11.true.j.0415" wn="1" wnkey="true%3:00:00::" text="The use of viral vectors should offer enhanced efficiencies and versatility for the expression of cloned genes in various cell types than approaches using expression plasmids that are printed on solid surfaces [ 15 16 ] . This might be particularly true to primary cells, which often show poor expression of encoded genes when plasmid-based expression vectors are used." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-3-4.anc" start="9834" end="9842" sStart="null" offset="12" sid="r8.suggest.v.0475" wn="3" wnkey="suggest%2:32:02::" text="This result suggests that the relatively low efficiency of immobilization of biotinylated adenoviral vectors is caused by their fluidic properties in wells, which allow only a fraction of viral particles to reach the well surface and be captured by streptavidin molecules on the well surface." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-3-4.anc" start="15440" end="15445" sStart="null" offset="284" sid="r7.serve.v.0655" wn="1" wnkey="serve%2:42:03::" text="Thus, unlike the infection of cells by free adenoviral vectors, the collision of viral particles with the cell surface and the amount of the primary receptor for adenoviral vectors (coxsackie-adenovirus receptor; CAR) on target cells might not serve as the primary determinants for the permissivity of the cells." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6750-3-4.anc" start="34442" end="34446" sStart="null" offset="0" sid="null" wn="1" wnkey="read%2:31:00::" text="All authors &lt;b&gt;read&lt;/b&gt; and approved the final manuscript." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-3-4.anc" start="16256" end="16260" sStart="null" offset="58" sid="r7.poor.j.0269" wn="4" wnkey="poor%3:00:02::" text="Thus, the expression of transgenes is extremely poor [ 12 ] . The expression of CAR on the surface of COLO205 cells is even lower than HT-29 cells, and such CAR expression can be seen on only about 50% of COLO205 cells." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-3-4.anc" start="23806" end="23810" sStart="null" offset="329" sid="r7.poor.j.0261" wn="4" wnkey="poor%3:00:02::" text="The use of viral vectors should offer enhanced efficiencies and versatility for the expression of cloned genes in various cell types than approaches using expression plasmids that are printed on solid surfaces [ 15 16 ] . This might be particularly true to primary cells, which often show poor expression of encoded genes when plasmid-based expression vectors are used." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-3-4.anc" start="16256" end="16260" sStart="null" offset="58" sid="r7.poor.j.0269" wn="4" wnkey="poor%3:00:02::" text="Thus, the expression of transgenes is extremely poor [ 12 ] . The expression of CAR on the surface of COLO205 cells is even lower than HT-29 cells, and such CAR expression can be seen on only about 50% of COLO205 cells." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-3-4.anc" start="23806" end="23810" sStart="null" offset="329" sid="r7.poor.j.0261" wn="4" wnkey="poor%3:00:02::" text="The use of viral vectors should offer enhanced efficiencies and versatility for the expression of cloned genes in various cell types than approaches using expression plasmids that are printed on solid surfaces [ 15 16 ] . This might be particularly true to primary cells, which often show poor expression of encoded genes when plasmid-based expression vectors are used." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-3-4.anc" start="10430" end="10437" sStart="null" offset="8" sid="null" wn="1" wnkey="number%1:07:00::" text="Varying numbers of biotinylated Ad5.CMV-LacZ (2." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-3-4.anc" start="10430" end="10437" sStart="null" offset="8" sid="null" wn="1" wnkey="number%1:07:00::" text="Varying numbers of biotinylated Ad5.CMV-LacZ (2." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-3-4.anc" start="10430" end="10437" sStart="null" offset="8" sid="null" wn="1" wnkey="number%1:07:00::" text="Varying numbers of biotinylated Ad5.CMV-LacZ (2." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-3-4.anc" start="10430" end="10437" sStart="null" offset="8" sid="null" wn="1" wnkey="number%1:07:00::" text="Varying numbers of biotinylated Ad5.CMV-LacZ (2." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-3-4.anc" start="12230" end="12236" sStart="null" offset="64" sid="r8.number.n.0231" wn="1" wnkey="number%1:07:00::" text="Thus, if the infectivity is compared using the actual number of viral particles present in each well, Ad5.CMV-LacZ, immobilized on streptavidin-coated wells, may possess an infectivity equivalent to that of free adenoviral vectors." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-3-4.anc" start="11722" end="11728" sStart="null" offset="11" sid="r8.number.n.0139" wn="1" wnkey="number%1:07:00::" text="Up to this number of viral particles per well, used for immobilization for biotinylated Ad5.CMV-LacZ or for transduction by free Ad5.CMV-LacZ in solution, immobilized adenoviral vectors showed lower infectivity than free viral vectors." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-3-4.anc" start="24465" end="24472" sStart="null" offset="16" sid="r10.control.n.0100" wn="1" wnkey="control%1:07:00::" text="5. Such precise control of the shapes and sizes of areas/regions of genetically engineered cells would be very difficult to achieve with free viral vectors, which can diffuse freely in solution." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-3-4.anc" start="24465" end="24472" sStart="null" offset="16" sid="r10.control.n.0100" wn="2" wnkey="control%1:24:00::" text="5. Such precise control of the shapes and sizes of areas/regions of genetically engineered cells would be very difficult to achieve with free viral vectors, which can diffuse freely in solution." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-3-4.anc" start="24465" end="24472" sStart="null" offset="16" sid="r10.control.n.0100" wn="5" wnkey="control%1:04:00::" text="5. Such precise control of the shapes and sizes of areas/regions of genetically engineered cells would be very difficult to achieve with free viral vectors, which can diffuse freely in solution." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-3-4.anc" start="24465" end="24472" sStart="null" offset="16" sid="r10.control.n.0100" wn="1" wnkey="control%1:07:00::" text="5. Such precise control of the shapes and sizes of areas/regions of genetically engineered cells would be very difficult to achieve with free viral vectors, which can diffuse freely in solution." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-3-4.anc" start="21878" end="21884" sStart="null" offset="28" sid="r9.appear.v.0538" wn="1" wnkey="appear%2:39:00::" text="Such internalization events appear to contribute substantially to the infectivity enhancement by virus-microbead conjugates." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-3-4.anc" start="8506" end="8513" sStart="null" offset="441" sid="r11.absence.n.0762" wn="1" wnkey="absence%1:26:00::" text="This result is in contrast with our previous study, which showed that greater than 95% of biotinylated Ad5.CMV-LacZ, prepared under the same conditions, can be readily captured on streptavidin-coated microbeads [ 10 ] . Thus, the relatively low immobilization efficiency of biotinylated Ad5.CMV-LacZ on the surface of streptavidin-coated wells is not attributable to the absence of accessible biotin moieties on the surfaces of a fraction of viral particles or the presence of unreacted biotinylation reagent in the biotinylated Ad5.CMV-LacZ preparations." />
  </sentences>
</list>